L.E.A.F. Pharmaceuticals LLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From L.E.A.F. Pharmaceuticals LLC
Amryt’s birch bark extract oleogel-S10 for Epidermolysis Bullosa patients might become only the third botanical drug to clear the FDA.
Results Recap: CRT In DC Features New Biotronik Stent Data, Encouraging TAVR Low-Risk Data; Ablative Systems’ Alcohol Renal Denervation
Medtech Insight's Results Recap covers major device trial results appearing on MedDeviceTracker. This week's edition, covering March 1 to March 7, includes results of late-breaking trials presented at the 2019 Cardiovascular Research Technologies (CRT) conference in Washington, DC, including new data supporting Biotronik’s biodegradable polymer sirolimus-eluting stent and the company’s resorbable magnesium stent, results of the LRT trial of transcatheter aortic valves in low-risk patients, plus promising clinical data supporting Ablative System’s alcohol renal-denervation system.
Among the medtech companies who have released their first-quarter 2017 sales and earnings, Johnson & Johnson and Merit Medical Systems reported progress in their long-term plans to reshape their medical device businesses, while Abbott and Zimmer Biomet received some bad news in the quarter. Smith & Nephew shows signs of a turnaround, and perennial "winner" Edwards Lifesciences provided updates on some important developments in their flagship transcatheter valve business.
Leaf Healthcare Inc. is betting that caregivers of bedridden patients at risk of developing pressure ulcers will be willing to follow a turn protocol based on feedback from the Leaf Patient Monitor. The disposable, wearable, wireless patient sensor monitors patient orientation, so that patients can be turned properly every two hours, day and night, during their stay.
- Monitoring Equipment & Devices
- Other Names / Subsidiaries
- L.E.A.F. Rwanda Ltd.